Results 61 to 70 of about 632,269 (164)
Fever Among Pertussis Cases Reported Through Enhanced Pertussis Surveillance, 2015–2022
Abstract Fever is not considered a typical presentation of pertussis. We characterized fever among 7840 pertussis cases from the Centers for Disease Control and Prevention's Enhanced Pertussis Surveillance with cough onset from 2015 to 2022. Ten percent of cases had a reported fever. The presence of fever should not rule out pertussis as
Michelle M Hughes +10 more
openaire +2 more sources
Bordetella pertussis surveillance in England and Wales: 1995–7
Available data sources on disease due to Bordetella pertussis, including notifications, hospital admissions, deaths, and an enhanced laboratory-based surveillance system commenced in January 1994, were reviewed for the period 1995–7. Pertussis notifications continued their approximately 3-year cycle although at historically reduced levels.
P G, Van Buynder +5 more
openaire +3 more sources
Pertussis surveillance in French hospitals: results from a 10 year period [PDF]
We present 10 years of results from a paediatrician hospital network surveillance in France, set up in 1996 to monitor the trend of pertussis (whooping cough) in children and the impact of the vaccination strategies. Microbiologists from 43 hospitals that participate in the network on a voluntary basis notify pertussis diagnosis, and paediatricians ...
I Bonmarin +6 more
openaire +2 more sources
RSV Monoclonal Antibody Implementation for At‐Risk Infants: Victoria, Australia's 2024 Experience
ABSTRACT Background New respiratory syncytial virus (RSV) preventative programs are launching globally. Our Australian jurisdiction implemented RSV monoclonal antibody provision via pediatric and perinatal hospitals for highest risk neonates and infants.
Jane Tuckerman +8 more
wiley +1 more source
Pertussis Surveillance in Private Pediatric Practices, France, 2002–2006
To the Editor: In France, pertussis epidemiology has been extensively studied since 1993. Immunization of children with a highly efficacious pertussis whole-cell (Pw) vaccine (Sanofi Pasteur MSD, Lyon, France) for 40 years (since 1966) has reduced the incidence of pertussis.
Nicole Guiso +10 more
openaire +3 more sources
Pertussis is a highly contagious bacterial disease of the respiratory tract that can be prevented by vaccination. Before the COVID-19 pandemic, the vaccine coverage rate for the third dose of a DPT-containing vaccine was 86%, with large disparities among
Lucia F. Bricks +2 more
doaj +1 more source
Understanding the Epidemiology of Pertussis in Denmark
Acta Paediatrica, Volume 115, Issue 11, Page 2625-2627, November 2026.
Tine Dalby +2 more
wiley +1 more source
Respiratory deaths in Bangladesh are frequently assigned non‐specific causes because of limited diagnostic information. Through stakeholder consultations, key informant interviews, microbiologist consultations, and literature review, 11 priority respiratory pathogens were identified for potential detection using post‐mortem nasal swab testing and ...
Ridwana Maher Manna +1 more
wiley +1 more source
Validating the Use of Google Trends to Enhance Pertussis Surveillance in California
Pertussis has recently re-emerged in the United States. Timely surveillance is vital to estimate the burden of this disease accurately and to guide public health response. However, the surveillance of pertussis is limited by delays in reporting, consolidation and dissemination of data to relevant stakeholders. We fit and assessed a real-time predictive
Pollett, Simon +7 more
openaire +2 more sources
MODERNIZATION OF GENEOTIPING OF STRAINS B. PERTUSSIS
The new rapid molecular genotyping method was developed for studying the structure of ptxP promoter of pertussis toxin. Method is based on PCR-RFLP analysis, which allows studying the specific restriction profiles of the B.
G. A. Ivashinnikova +4 more
doaj +1 more source

